Pleural mesothelial cells in pleural and lung diseases

Medicine & Life Sciences

• Pleural Diseases 100%
• Lung Diseases 61%
• Idiopathic Pulmonary Fibrosis 27%
• Mesoderm 16%
• Fibrosis 11%
• Malignant Pleural Effusion 10%
• Pathogen-Associated Molecular Pattern Molecules 10%
• Adherens Junctions 9%
• Catenins 9%
• Endoderm 9%
• Cytokines 9%
• Malignant Mesothelioma 9%
• Asbestos 8%
• Pleura 8%
• Platelet-Derived Growth Factor 8%
• Toll-Like Receptors 8%
• Lung 8%
• Fibroblast Growth Factor 2 8%
• Pleural Effusion 7%
• Transforming Growth Factors 7%
• Epithelial-Mesenchymal Transition 7%
• Fibrin 7%
• Adaptive Immunity 7%
• Cadherins 7%
• Innate Immunity 7%
• Endothelium 6%
• Smooth Muscle Myocytes 6%
• Vascular Endothelial Growth Factor A 6%
• Epithelium 5%
• Phosphorylation 5%
• Biomarkers 4%
• Inflammation 4%
• Therapeutics 3%
• Infections 3%
• Proteins 2%